High blood pressure medication strategy proves effective in Hispanic women

at less than 140/90 mmHg, was achieved in 75 percent of Hispanic women and 68 percent of non-Hispanic white women.

And despite having a higher prevalence of diabetes at baseline, only 5.7 percent of Hispanic women suffered from adverse cardiovascular outcomes, compared with 12.3 percent of non-Hispanic white women.

Cooper-DeHoff attributed the low incidence of adverse outcomes to the fact that Hispanic women enrolled in the study were younger. If follow-up had continued over a longer period of time, adverse outcomes in the Hispanic women may have increased, she said.

However, these women remained at a lower risk for these outcomes even after statisticians adjusted for age and other factors. Still, she warned that problems associated with diabetes are likely to show up in these patients down the road.

Diabetes in and of itself imparts significant future adverse cardiovascular outcomes, she said. These women should be well-monitored under the care of a physician so that they can prevent future cardiovascular morbidity and mortality related to hypertension and diabetes. Importantly, because the Hispanic population is the fastest-growing ethnic minority in the United States, Hispanics especially women should be included in future cardiovascular research in order to further our understanding of these high-risk diseases in Hispanic patients.

High blood pressure is becoming more prevalent in women across all ethnic groups, Cooper-DeHoff said. And although it is thought to actually be less common in Hispanic women, fewer Hispanics have been included in hypertension studies.

The INVEST findings are important because they demonstrate that this treatment for Hispanic women really pays off, said Thomas G. Pickering, M.D., D. Phil., director of the Center for Behavioral Cardiovascular Health at Columbia University Medical Center. Theyve got something really interesting with this study, and it wasnt something that cou

Contact: Amelia Beck
University of Florida

Page: 1 2 3

Related biology news :

1. High blood pressure, low energy -- a recipe for heart failure
2. Brain blood flow gives clues to treating depression
3. Study finds gender differences in renal and other genes contributing to blood pressure
4. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
5. Research aims to identify markers for menopausal women at risk for deadly blood clot
6. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells
7. A low expression of MX2 gene exists in the white blood cells of narcoleptics
8. How a pain in the neck could be bad for your blood pressure
9. Penn researchers discover pathway that eliminates genetic defects in red blood cells
10. U-M team identifies gene that regulates blood-forming fetal stem cells
11. MicroRNA works with Ago2 protein to regulate blood cell development

Post Your Comments:

(Date:7/31/2020)... ... July 30, 2020 , ... ... product portfolio with a near term focus on Type 2 diabetes and associated ... experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in ... on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor ... live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition ...
(Date:7/1/2020)... VENICE, Calif. (PRWEB) , ... July 01, 2020 ... ... focused on building awareness and solutions for glioblastoma—the most common and aggressive adult ... and Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... 13, 2020 , ... True Terpenes , the leading platform for terpene ... (SAB) to research the medical potential of terpenes and the potential entourage effect ... The board is focused on expanding the recently launched line of effects-based terpenes - ...
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:7/31/2020)... ... 2020 , ... R3 Stem Cell International is now offering patients the opportunity ... cells total, patients may choose which extremities they would like treated. , Several studies ... Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... that they have entered into a strategic partnership whereby Catalent will provide support ...
Breaking Biology Technology:
Cached News: